MassMutual Private Wealth & Trust FSB raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 648.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,422 shares of the medical instruments supplier’s stock after acquiring an additional 1,232 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in DENTSPLY SIRONA were worth $27,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. increased its stake in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after acquiring an additional 753 shares during the period. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at $27,000. Kennebec Savings Bank acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth $35,000. Van ECK Associates Corp bought a new position in DENTSPLY SIRONA in the third quarter valued at about $42,000. Finally, Allworth Financial LP lifted its holdings in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 625 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on XRAY shares. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Finally, Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their price target for the stock from $30.00 to $20.00 in a report on Thursday. Ten research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $26.67.
DENTSPLY SIRONA Trading Up 0.5 %
Shares of XRAY opened at $19.53 on Friday. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $35.68. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The stock has a market cap of $3.88 billion, a PE ratio of -9.43, a P/E/G ratio of 1.80 and a beta of 0.96. The business’s 50-day moving average price is $19.03 and its 200-day moving average price is $22.67.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter last year, the company earned $0.49 earnings per share. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.28%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -30.92%.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories
- Five stocks we like better than DENTSPLY SIRONA
- What Are Growth Stocks and Investing in Them
- Bloom Energy: Powering the Future With Decentralized Energy
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What is diluted earnings per share (Diluted EPS)?
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.